These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9377699)

  • 41. [The dilemma of effectiveness and economic value of alternative medicine].
    Marx HH
    Gesundheitswesen; 1997 May; 59(5):297-301. PubMed ID: 9289220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis.
    Ganiats TG
    Prim Care; 1995 Jun; 22(2):307-18. PubMed ID: 7617789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Setting priorities in and for end-of-life care: challenges in the application of economic evaluation.
    Normand C
    Health Econ Policy Law; 2012 Oct; 7(4):431-9. PubMed ID: 23079301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficiency frontier approach to economic evaluation: will it help German policy making?
    Brouwer WB; Rutten FF
    Health Econ; 2010 Oct; 19(10):1128-31. PubMed ID: 20641141
    [No Abstract]   [Full Text] [Related]  

  • 45. [Quality assurance in neuroradiology].
    Huk WJ
    Aktuelle Radiol; 1995 Nov; 5(6):343-5. PubMed ID: 8580129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How health economic evaluation (HEE) contributes to decision-making in public health care: the case of Brazil.
    Elias FT; Araújo DV
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):405-12. PubMed ID: 25444299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Networking nursing in the national and international context: requirements under economic factors].
    Conrad J
    Pflege Z; 2010 Sep; 63(9):544-7. PubMed ID: 20922980
    [No Abstract]   [Full Text] [Related]  

  • 48. Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?
    Husereau D; Marshall DA; Levy AR; Peacock S; Hoch JS
    Int J Technol Assess Health Care; 2014 Apr; 30(2):179-87. PubMed ID: 24806420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical community should focus on technology assessment.
    Uzych L
    Tex Med; 1990 Apr; 86(4):7. PubMed ID: 2110687
    [No Abstract]   [Full Text] [Related]  

  • 50. Observations on primary health care in Ontario, Canada.
    Rimmer EM
    Br J Gen Pract; 1990 Jul; 40(336):300-2. PubMed ID: 2127896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Quality evaluation in endoscopy].
    Riemann JF; Birkner B; Hahn EG
    Internist (Berl); 1996 Aug; 37(8):830-8. PubMed ID: 8964675
    [No Abstract]   [Full Text] [Related]  

  • 52. Health technology assessment and economic evaluation across jurisdictions.
    Simoens S
    Value Health; 2010; 13(6):857-9. PubMed ID: 20701730
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of medical products is possible. 5. Discussion forum of GFR abd IQWiG was devoted to studies of the therapeutic treatment with medical products].
    Adler G; Windeler J
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):313-4. PubMed ID: 22818146
    [No Abstract]   [Full Text] [Related]  

  • 54. Implications of molecular diagnostics on health outcomes and cost in quality-of-care initiatives.
    Bruins C
    Manag Care; 2010 Oct; 19(10 Suppl 4):12-5. PubMed ID: 21132895
    [No Abstract]   [Full Text] [Related]  

  • 55. Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods.
    Sculpher M; Claxton K
    Health Econ; 2010 Oct; 19(10):1132-6. PubMed ID: 20662107
    [No Abstract]   [Full Text] [Related]  

  • 56. Health care technology assessment and transfer.
    Boos N
    Eur Spine J; 2007 Aug; 16(8):1291-2. PubMed ID: 17636348
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effectiveness, quality and economic aspects].
    Conen D
    Leber Magen Darm; 1990 Jan; 20(1):7-10. PubMed ID: 2107371
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical use of decision analysis.
    Lawler FH
    Prim Care; 1995 Jun; 22(2):281-93. PubMed ID: 7617787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Optimal medical performance develops on the decision tree. Decision methodology and analysis--clinical economy series, 6].
    Szucs TD
    Fortschr Med; 1995 Sep; 113(26):55-8. PubMed ID: 7498859
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effectiveness and cost effectiveness of innovative medical techniques in public health].
    Stehr H
    Radiologe; 1996 Apr; 36(4):279-84. PubMed ID: 8677319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.